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Abstract
Background: Detection of immunogenic proteins remains an important task for life sciences as it nourishes the
understanding of pathogenicity, illuminates new potential vaccine candidates and broadens the spectrum of
biomarkers applicable in diagnostic tools. Traditionally, immunoscreenings of expression libraries via polyclonal sera
on nitrocellulose membranes or screenings of whole proteome lysates in 2-D gel electrophoresis are performed.
However, these methods feature some rather inconvenient disadvantages. Screening of expression libraries to
expose novel antigens from bacteria often lead to an abundance of false positive signals owing to the high cross
reactivity of polyclonal antibodies towards the proteins of the expression host. A method is presented that
overcomes many disadvantages of the old procedures.
Results: Four proteins that have previously been described as immunogenic have successfully been assessed
immunogenic abilities with our method. One protein with no known immunogenic behaviour before suggested
potential immunogenicity.
We incorporated a fusion tag prior to our genes of interest and attached the expressed fusion proteins covalently
on microarrays. This enhances the specific binding of the proteins compared to nitrocellulose. Thus, it helps to
reduce the number of false positives significantly. It enables us to screen for immunogenic proteins in a shorter
time, with more samples and statistical reliability. We validated our method by employing several known genes
from Campylobacter jejuni NCTC 11168.
Conclusions: The method presented offers a new approach for screening of bacterial expression libraries to
illuminate novel proteins with immunogenic features. It could provide a powerful and attractive alternative to
existing methods and help to detect and identify vaccine candidates, biomarkers and potential virulence-associated
factors with immunogenic behaviour furthering the knowledge of virulence and pathogenicity of studied bacteria.
Background
Campylobacter jejuni is one of the principal causing agents
of bacterial gastroenteritis in industrialized countries [1].
From January to mid September 2011 52.940 Campylobac-
ter infections have occurred in Germany alone [2].
Although infections predominantly result in mild self-lim-
iting gastroenteritis, in some cases severe post-infection
ramifications have been reported with the Guillain-Barré
syndrome the major contributor [3]. The main route of
infection and transmission is believed to be the incorrect
handling and incomplete cooking of poultry. In fact,
studies mention 62% of poultry carcasses to be contami-
nated with Campylobacter after slaughter [4].
On account of its widespread occurrence and clinical
relevance testing for contamination of meat or the pre-
sence of Campylobacter infections in patients is neces-
sary. Although several genomic typing methods exist
[5,6] these are often time-consuming and laborious. In
comparison, a rapid point-of-care device would need a
more direct approach like the presence of antigens
which react swiftly with specific antibodies. For many
pathogens several different methods based on the anti-
gen-antibody-reaction are already commercially avail-
a b l e ,e . g .L a t e x - A g g l u t i n a t i o n - T e s t s[ 7 ] .H o w e v e r ,t h e
knowledge of antigens for pathogens is often limited.
Traditionally, testing for immunogenic proteins has
been carried out by screening of expression libraries
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city, this method has a key shortcoming regarding bac-
terial proteins. The elucidation of novel antigens is
extremely difficult as a result of the high cross-reactivity
of polyclonal antibodies against the host bacterium of
the library [9]. Therefore, a high number of false posi-
tives occur, which hinder a fast and successful search
for new antigens.
With the emergence of fusion tags, protein purification
has become more convenient. Several tags have been
established and frequently used in all kinds of applications.
Apart from other commonly used tags such as GST
[10,11], MBP [12,13] or 6xHis [14,15] the HaloTag
® (Pro-
mega) features several unique characteristics. The Halo-
Tag
® and its ligand bind covalently, leading to a strong,
irreversible bond [16]. Further, it increases the amount of
soluble protein expressed in contrast to other tags [17], as
it reduces the formation of inclusion bodies during recom-
binant protein expression.
In this paper, we describe a method to covalently attach
different HaloTag
® fusion proteins on HaloLink™ slides
(see Figure 1) and consequently perform an immunoscre-
ening using polyclonal antibodies in a microarray format,
which is a suitable method for high-throughput applica-
tions such as screening of entire expression libraries
(see Figure 2). This method reduces the pitfall of cross-
reactive signals normally encountered with screenings
and leads to a more rapid detection of immunogenic pro-
teins compared to conventional methods.
Furthermore we show the outstanding performance of
this method by expressing and detecting several proteins
from Campylobacter jejuni previously described as
immunogenic. As controls of the screening process, we
included proteins from Campylobacter which have not
been described as immunogenic before.
Results
We successfully amplified all but one gene (cfrA)f r o m
the genomic DNA of Camyplobacter jejuni. All eleven
genes that were successfully amplified showed the correct
length (see Figure 3) and were subsequently cloned to
KRX single-step competent cells. The correct insert size
was determined by Colony PCR. Plasmids from clones
containing the correct-sized inserts were isolated and the
MCS was sequenced using both a forward and a reverse
primer (HT7 For and Flexi R). During cloning an extra
GTT, which encodes for a valine residue in the proteins’
primary structures, was inserted immediately prior to
each stop codon. As a universal stop codon TAA was
used, replacing other stop codons if present. This was
mainly done to gain maximum flexibility during cloning
as the Flexi vector system enables the direct transfer to
other vectors with different tags. A GTT is mandatory to
later transfer the gene of interest to a vector encoding a
C-terminal tag.
For that reason, no 100% identity can be observed,
when comparing the sequencing results with the original
gene sequences from EMBL using a global alignment
with free-end gaps. Nine of the plasmids differed only in
the additional GTT mentioned above. For pyrC the usual
stop codon TGA was replaced by TAA causing minor
discrepancy in the alignment. The longest gene under
investigation, flaA demonstrated the least conformity to
t h er e s p e c t i v es e q u e n c ef r o mE M B L .T h el e n g t ho fe a c h
sequence reaction was approximately 1300 nucleotides.
Due to the numerous alterations in the sequence causing
a shift in amino acid sequence, flaA was omitted from
future investigation.
The correct expression of the encoded fusion proteins
was assessed by SDS-Page. Analyzing the gel under fluor-
escent conditions reveals protein bands which have the
HaloTag
® ligand attached. The PageRuler Plus prestained
Protein ladder possesses two fluorescent bands, at 25 and
70 kDa respectively. HaloTag
® Standard Protein with a
Figure 1 Detection of immunogenic proteins on microarrays.T h e
cell lysates are spotted onto HaloLink™ slides (shaded area) with
immobilized ligand (curved lines). The HaloTag
® (pink sector) is fused
to the N-terminus of the protein of interest (purple sector) and
attaches covalently to the ligand. Thus, the protein of interest is
covalently attached to the surface prior to screening, whereas other
proteins from the cell lysate are unbound and washed away after the
coupling reaction. Subsequently, primary antibodies (blue) bind to the
protein of interest. Afterwards, secondary antibodies (black) conjugated
with a fluorophore (yellow) bind to the respective primary antibody.
The fluorescent dye is used for detection of positive spots identifying
sites of potential immunogenic proteins in the process.
Hoppe et al. Journal of Nanobiotechnology 2012, 10:12
http://www.jnanobiotechnology.com/content/10/1/12
Page 2 of 12size of 60 kDa was also analyzed and helps as an additional
size reference. The HaloTag
® features a size of 34 kDa
alone.
For ease of use and brevity the expressed proteins are
abbreviated and referred to as their corresponding gene
names in plain text, e.g. pseB as the protein encoded by
the gene pseB. Full protein names for each gene as taken
from the KEGG database can be found in Table 1.
Most of the fusion proteins investigated fall into a range
between 61 and 73 kDa, namely HaloTag
® fused to argC
(73 kDa), pyrC (72 kDa), pseB (71 kDa), gapA (70 kDa),
cjaA (65 kDa), peb1 (62 kDa), hisJ (62 kDa) and flaC
(61 kDa). Outside of this size range, only HaloTag
®-flaA
(93 kDa) and the small HaloTag
®-pal (52 kDa) are found.
For each protein, bands with the correct size could be
detected, see Figure 4. Additionally, bands of smaller size
are visible (34 kDA) which might be due to untimely ter-
mination of translation, potentially comprising only the
HaloTag
®, which features the corresponding size.
The cell lysates containing the expressed fusion pro-
teins were spotted to HaloLink™ Slides (Promega) by
the QArray2 microarray spotter. For the spotting layout
see Figure 5.
The immunogenicity of the immobilized proteins was
assessed using polyclonal antibodies raised against whole
and partially lysed attenuated cells of Campylobacter
jejuni. Secondary antibodies conjugated with a fluoro-
phore were used to detect signals. For better compar-
ability the raw data was processed and contrast values
were calculated.
Figure 6 shows the resulting bar chart of the pro-
cessed data of one slide. Four proteins showed contrast
values above the cutoff. The contrast values ± s.d. for
each of these proteins were 0.63 ± 0.17 (cjaA), 0.47 ±
0.10 (hisJ), 0.35 ± 0.05 (flaC) and 0.68 ± 0.15 (peb1a)
respectively. In comparison, the contrast values of the
following proteins were significantly below the cutoff:
0.06 ± 0.20 (gapA), 0.08 ± 0.15 (pyrC) and 0.09 ± 0.04
(argC). The last two proteins - pal and pseB - led to
contrast values of 0.17 ± 0.11 (pal) and 0.25 ± 0.05
(pseB), which albeit closer are still slightly below the
cutoff of 0.25.
Figure 2 Advantages of microarray platform for screening. The
method could readily be adapted to screen large expression
libraries either from a cDNA or genomic source. Clones carrying
different inserts are assigned unique positions in microtiter plates.
Subsequently clones are cultivated, protein expression is induced
and finally cells are lysed. The whole lysates can directly be spotted
to the HaloLink™ Arrays rendering additional time-consuming and
costly purification steps obsolete. As only fusion proteins will bind
to the ligand, remaining proteins from the lysates are simply
washed off after spotting minimizing background and cross-
reactivity during the subsequent screening steps. The microarray
platform allows for several thousand spots per slide allowing for
easy high-throughput screening applications.
Figure 3 Agarose gel of PCR products after amplification of
Campylobacter jejuni genes from genomic DNA. The band sizes
match the respective length of each gene. Refer to Table 2 for
expected gene lengths. As markers Hyper Ladder I (M) and II (M2)
were used both supplied by Bioline.
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cates (n = 5) were analyzed. Summing up the results of
all slides, a box-whisker-plot was composed, see Figure
7. The replicates emphasized the results from the one
slide above. CjaA, hisJ, flaC and peb1a were clearly
above the respective cutoffs and led to positive signals
in all the slides. On the contrary, gapA, argC and pyrC
were significantly below the cutoff. The tendency of pal
and pseB to fall within close proximity of the cutoff is
observed throughout the replicates.
Further verification of the results was performed by
using a standard western blot experiment to test for
immunogenicity. Figure 8 shows the results of the inves-
tigated proteins after purification with HaloLink™ mag-
netic beads was performed prior to SDS-PAGE and
blotting. Only two of the investigated immunogenic pro-
teins (cjaA, and hisJ) show strong visible bands in wes-
tern blot matching the expected sizes. The three
remaining immunogenic prote i n s ,p e b 1 a ,f l a Ca n dp a l ,
Table 1 Proteins encoded by genes used in this study.
Gene Protein Abbreviation
cjaA putative amino-acid transporter periplasmic solute-binding protein cjaA
hisJ histidine-binding protein precursor hisJ
pal peptidoglycan associated lipoprotein pal
cfrA ferric enterobactin uptake receptor cfrA
flaC flagellin flaC
flaA flagellin flaA
peb1a bifunctional adhesin/ABC transporter aspartate/glutamate-binding protein peb1a
cadF OmpA-OmpF porin cadF
pyrC dihydroorotase (EC:3.5.2.3) pyrC
pseB UDP-GlcNAc-specific C4,6 dehydratase/C5 epimerase pseB
gapA glyceraldehyde 3-phosphate dehydrogenase (EC:1.2.1.12) gapA
argC N-acetyl-gamma-glutamyl-phosphate reductase (EC:1.2.1.38) argC
The full names of each protein investigated are given according to the KEGG database with their coding genes. The gene names were used as abbreviations for
the proteins in this paper
Figure 4 SDS-PAGE of HaloTag
® fusion proteins incubated with
HaloTag
® Alexa Fluor 488 ligand. M refers to PageRuler Plus
prestained protein ladder (Fermentas) with fluorescent bands at 70
kDa and 25 kDa, The HaloTag
® standard protein (HT-SP) was added
as an additional size reference at 60 kDa. The bands match the
expected sizes for each fusion protein. Additionally small fragments
of only HaloTag
® (34 kDa) are visible which might be due to early-
terminated translation.
Figure 5 Spotting layout. The rectangular matrix within the
picture marks one subarray. The corresponding samples are
presented at the bottom. SP is the abbreviation for HaloTag
®
standard protein with the number referring to the concentration of
standard protein in the spotted solution in μg/ml. The gene names
refer to the locations were corresponding fusion protein was
released, KRX is cell extract without any fusion protein and PBS
represents the buffer control. Each sample was spotted at least in
duplicate.
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as all the other proteins. Additionally, a Dotblot was
performed (Figure 9) with the purified proteins, which
showed clear positive signals for cjaA and hisJ, a rather
weak signal for peb1a and extremely low signals for flaC
and pal.
In contrast, Figure 10 shows a western blot performed
directly with whole lysates after recombinant expression
without further purification. At least four bands are visi-
ble in all the samples with the most prominent band at
70 kDa. Bands of lower intensity appear at approximately
55 kDa, 28 kDa and 18 kDa. The first five lanes, corre-
sponding to the known immunogenic proteins, cjaA, hisJ,
peb1a, flaC and pal, show bands of higher intensity than
the remaining five lanes. However, as the investigated
fusion proteins fall either into the 70 kDa or in case of
HT-pal into the 55 kDa range, a clear differentiation
between positive bands and background caused by KRX
cross-reactive proteins is hardly possible.
Discussion
Using our new method, we were able to express, immobi-
lize and screen all of nine different proteins from Campy-
lobacter jejuni using HaloTag
® and KRX cells. CjaA, hisJ,
flaC, peb1A and pal act immunogenic as described else-
where [18-23]. GapA, pyrC, argC and pseB have not been
reported as immunogenic before. Immunoscreening on
Figure 6 Contrast value for one microarray slide.T h eb a r s
represent the median. The standard deviation (SD) is accounted for
by the error bars. KRX represents cell lysate without HaloTag
®
protein and PBS was spotted as a buffer control. The cutoff is
represented by a bold horizontal line. Four proteins namely cjaA,
hisJ, flaC and peb1a are above the cutoff. In comparison, gapA, pyrC
and argC lie significantly below the cutoff value. Two proteins - pal
and pseB - are approximately at the cutoff. The contrasts for KRX
and PBS are at or below zero.
Figure 7 Contrast values from all replicates. The contrast values
(n = 5) are presented as a box-whisker-plot where the square
represents the arithmetic mean and the horizontal line the median.
The whiskers enclose 90% of all values (95% - 5%) and 98% of the
values fall between the crosses. CjaA, hisJ, flaC and peb1a show
positive signals above the cutoff throughout the slides with only
one exception for flaC due to an outlier in the cutoff. On the other
hand, gapA, argC and pyrC show negative results, i.e. contrast
values significantly below the respective cutoff values for all the
slides. The remaining proteins pal and pseB are in the range of the
cutoff values.
Figure 8 Western Blot of purified protein. CjaA and hisJ show
strong bands of the corresponding sizes (31 kDa and 28 kDa) after
removal of the HaloTag
®. The remaining proteins cannot be
detected in western blot by visual means.
Figure 9 Dot Blot of purified protein. CjaA, hisJ and peb1a show
positive signals, flaC and pal show extremely weak signals at best
but are hardly distinguishable from the background. The rest is
clearly negative showing no signals at all.
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icantly below the cutoff and can be considered negative.
Further, different codon usage between these two organ-
isms (Campylobacter jejuni and Escherichia coli) might be
the cause for low expression (see Additional file 1: Codo-
nusage 1). This could have been a problem in the expres-
sion of pal and possibly to an extent for flaC explaining
the low signals in microarray and more prominently in
western blot analysis and dotblot. Nevertheless, four pro-
teins with known immunogenic ability have been success-
fully detected with strong signals clearly above the cutoff.
So far, pseB has not been described as immunogenic,
although it is involved in the glycosylation of the flagellar
apparatus of Campylobacter jejuni [24,25]. Although the
signals are far weaker than for known antigens such as
cjaA, hisJ or peb1a, the results suggested immunogenic
potential of pseB to be in the realm of possibility. The
close proximity and involvement in the modification of
flagellin, which is known to be immunogenic as well as
highly exposed, suggests immunogenic behavior of pseB
to be plausible. However, western blot and dot blot ana-
lyses have revealed no band or signal for pseB, which is
in accordance to the microarray data. The contrast values
were below the cutoff and no band was visible in western
blot experiments.
Directly analyzing the whole lysates by western blot
failed to discriminate between positive bands and back-
ground as the whole lysates of KRX cells clearly show
cross-reactive signals with the used polyclonal antibody.
However, as these bands bear similar sizes as the investi-
gated fusion proteins, a secure identification of true posi-
tives is difficult at best using standard western blot
without previous purification methods. Even then identifi-
cation of immunogenicity is sometimes difficult at best as
sensitivity might be low due to differences in expression
rate and losses of protein content during purification. Still,
the signal intensities of the five immunogenic proteins
were well represented by all three methods - microarray,
western blot and dot blot, as those with highest contrast
values, namely cjaA, hisJ and peb1a, have also shown
bands in western blot and signals in dot blot albeit lower
for peb1a. In contrast, pal failed to generate a positive sig-
nal during microarray experiments and this result could
be confirmed by western blot and dot blot. For flaC no
band is visible in western blot and the signal in dot blot is
extremely weak, yet our microarray method has identified
the protein as being immunogenic, which has been
reported elsewhere. A possible explanation for this is the
high sensitivity of microarrays. This is well in accordance
to Ekins “ambient analyte theory” [26] which has been the
basic concept of microarrays for several decades. Thus, the
microarray method might well be superior for immunoas-
says than common blotting methods.
Conclusions
We were able to clone several genes from Campylobacter
jejuni into KRX cells, to express the respective proteins as
fusion constructs with a HaloTag
® attached to their N-
Terminus and to immobilize these proteins on microarray
surfaces. Subsequently, we have succeeded in screening
the proteins using polyclonal antibodies to detect their
immunogenic abilities. The usage of pFN18A Flexi vector
in combination with KRX cells offers various advantages.
First, Flexi vectors inhabit several intriguing features. They
encode a bacterial RNase - Barnase - which is only
removed during successful cloning. If cloning fails, the
Barnase remains intact and leads to cell death and no visi-
ble colonies on the plates. The HaloTag
®- a derivative of a
Dehalogenase - is fused during expression to the N-termi-
nus of our protein of interest. The expression of the fusion
proteins is under control of T7 RNA Polymerase. Addi-
tionally, an ampicillin cassette is present to allow for anti-
biotic selection.
Second, with commonly used BL21(DE3) expression
cells, induction is realized by isopropyl b-D-1-thiogalac-
topyranoside (IPTG). However, the IPTG-induced
expression of T7 RNA Polymerase in BL21(DE3) is not
tightly regulated, i.e. the promoter is leaky, causing a
basal expression even if cells are not induced. This is a
Figure 10 Western Blot of whole cell lysates. Four bands are
visible in the KRX whole cell lysate with a more prominent band at
70 kDa and three weaker bands at 55 kDa, 28 kDa and roughly 18
kDa. These bands are most likely due to cross-reactive proteins
within the E.coli lysates. All four proteins previously described as
non-immunogenic (argC, gapA, pseB and pyrC) show band patterns
highly similar to KRX. This underlines their lack of immunogenic
potential. The five proteins previously described as immunogenic
elsewhere show stronger bands at roughly 70 kDa for cjaA, hisJ,
peb1a, flaC and 55 kDa for pal respectively. These sizes correspond
closely to the expected sizes of the HaloTag
® fusion proteins.
However, the interference of the background bands from KRX -
being in the same range as the target proteins under investigations
- prevents a secure identification of immunogenic proteins.
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expressed [27]. In our method, we used KRX cells to
counter this problem. These cells are under regulation of
L-Rhamnose and induction can completely be turned off
by addition of glucose to the medium during growth. In
fact, for the proteins investigated, expression has failed in
BL21(De3) for all but two proteins (data not shown),
whereas KRX cells were able to express all the proteins
with satisfying yields as we showed by SDS-PAGE.
Third, the HaloTag
® offers covalent binding to its spe-
cific ligand, therefore leading to a strong attachment of
the proteins to the microarray surface in comparison to
other tags such as GST or 6 × His. Expression, immobi-
lization to modified surfaces and detection of antigens
was difficult at best using 6 × His and GST (data not
shown).
Combining these features with microarrays, we have
been able to employ a method to rapidly screen for immu-
nogenic proteins without the need for an additional purifi-
cation step. Instead whole lysates can directly be spotted
to the microarray surface. Still, cross-reactivity is pre-
vented by the special use of the Tag and its specific ligand
on the microarray slide. Further, the use of microarrays as
a screening platform offers several advantages in itself.
High throughput, statistical testing of the data and numer-
ous replicates are easily achieved compared to the more
traditional screening on nitrocellulose membranes.
In fact, numerous replications with nitrocellulose mem-
branes are difficult, the selection of positive clones error-
prone as replicate and master filters have to be compared
visually and selection occurs manually. Moreover, nitrocel-
lulose membranes bind entire protein lysates unable to
discriminate between proteins of interest and proteins
from the expression host. This high background content
leads to numerous false positive signals when using poly-
clonal sera raised against whole cells to search for new
antigens. Although, these effects might differ for different
bacteria, in case of Campylobacter jejuni and Escherichia
coli this has been observed previously as their outer mem-
brane proteins (OMP) show high similarities [28]. On top
of that, identification of positive clones is merely done
visually, usually by chemiluminescence.
With our method, these problems are minimized. It
allows screening of numerous clones on microarrays with
sufficient replicates to gain statistically significant data. It
reduces the occurrence of false positive signals to a mini-
mum, thus focusing on the real positive proteins and lead-
ing to a faster detection. It allows for statistical and
mathematical analysis of the data compared to nitrocellu-
lose membranes illuminating proteins with different
strength in their immunogenic ability. Further, the choice
of our expression host - KRX - and the HaloTag
® have
brought other benefits, as well. The expression is tightly
regulated, offers high yields and the covalent attachment
of the proteins to the surface makes separate purification
obsolete as it combines spotting and purification directly.
The overall time frame from cultivation to screening is
roughly 30 hours, whereas immunoscreening on nitrocel-
lulose membranes [8] takes at least 3 days. The benefit of
low turn-around time increases, when taking the cloning
into consideration. Normally, cloning to recombinant
expressed proteins is first done in propagation cells such
as JM109 or DH5a and afterwards a second cloning pro-
cedure to expression cells as BL21(DE3) is performed.
With KRX single-step cells both propagation and expres-
sion can be performed sequentially avoiding time-consum-
ing plasmid preparations and additional cloning steps.
Our results proved to be reproducible, which we
showed using several technical replicates.
The HaloTag
® has previously been used for an increas-
ing spectrum of applications, such as the monitoring of
single molecules during trans-translation processes [29],
reporter protein assays for magnetic resonance imaging
(MRI) analysis [30] and flow cytometry [31]. With our
method, we have added another intriguing application to
the mix. This method ought to become an attractive alter-
native to traditional methods for immunoscreening as it
features several unique advantages. It provides a low turn-
around time, significantly reduces background and false
positive signals and enables high-throughput screenings of
expression libraries or other sources of hundreds and
thousands of different clones. With our results we were
able to show the great potential of this method in future
full proteome screenings as an attractive alternative to
other broad screenings. Its major advantages being the
complete deletion of cross-reactivity to proteins of the
expression host as these are simply washed off after spot-
ting. Thus an additional purification step, which is usually
performed in microarray-based screening approaches of
expression libraries or proteome analysis before immobili-
zation to Nitrocellulose slides [32], becomes obsolete.
Therefore, this method might decrease time and material
costs associated with extensive screenings of libraries.
These advantages increase significantly with the number
of different samples processed, making library screening a
preferred application.
For screening of whole expression libraries and the
detection of novel antigens the use of different polyclonal
sera and antibodies is necessary as these might detect dif-
ferent antigens. Only if a protein leads to positive signals
in all screenings it can be considered immunogenic. Addi-
tionally, controls using established methods such as wes-
tern blot, immunoprecipitation and ELISA ought to be
considered to validate the potential of a novel antigen.
Consequently, the method presented herein may be
useful for broad screening of bacterial expression
libraries to identify and detect novel immunogenic pro-
teins. Our approach gives the possibility to discover new
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assays or for the production of vaccines. Additionally,
further knowledge about potentially new virulence-asso-
ciated factors and antigens will grant deeper insight and
understanding of virulence and pathogenicity of many
enigmatic bacteria. Therefore, we strongly believe this to
emerge as an important tool in the search for antigens,
virulence factors, biomarkers and vaccine candidates.
Methods
Bacterial cultivation
Campylobacter jejuni NCTC 11168 was used for isola-
tion of genomic DNA and amplification of genes used
in this study. Campylobacter jejuni NCTC 11168 was
streaked on Karmali Agar (Oxoid) and incubated under
microaerophilic conditions at 42°C for at least 2 days.
For genomic DNA isolation a flask of 100 ml brain-
heart-infusion (BHI) broth was inoculated with a loop of
bacterial culture and cultivated in an Innova 40R (New
Brunswick) incubation shaker for 48 h at 42°C in an
anaerobic jar.
Genomic DNA isolation
Genomic DNA of Campylobacter jejuni NCTC 11168 was
isolated using a phenol-chloroform protocol. Briefly, cells
were harvested by centrifugation (1000 g, 10 minutes) in a
benchtop centrifuge 5415 R (Eppendorf) and the pellet
r e s u s p e n d e di n1m lo f1×P B S( 1 . 9m MN a H 2PO4,
8.1 mM Na2HPO4, 150 mM NaCl). After a second centri-
fugation the pellet was resuspended in 500 μl of lysis buf-
fer (10 mM Tris, pH 7.5, 25 mM EDTA, 75 mM NaCl,
0.1% SDS and 0.5 mg/ml Proteinase K) and incubated
for 1 h at 50°C. Afterwards one volume of phenol-chloro-
form-isoamyl alcohol (25:24:1) was added and after centri-
fugation (> 13.000 g, 1 min) the DNA-containing top
phase was carefully removed and transferred to a clean
tube. This step was repeated three times and the com-
bined top phases washed twice with chloroform-isoamyl
alcohol (24:1). After addition of 1/10 volume of 3 M
sodium acetate and one volume of 100% isopropanol the
solution was centrifuged for 30 min at 13.000 g. The
supernatant was discarded, the pellet air-dried and resus-
pended in 100 μl Tris-Cl (pH 8.5). The concentration
and purity of the isolated DNA was measured using the
Nanodrop ND-1000 device (Peqlab).
Amplification of genes of interest
PCR was carried out to selectively amplify several genes
of interest from the genomic DNA. The primers were
designed using Flexi Vector Primer Design Tool (Pro-
mega) and possessed overhangs for subsequent cloning
into Flexi Vectors (Promega). The melting temperature
of each primer was determined using a Tm calculator
(Finnzymes). Table 2 summarizes primer sequences and
melting points.
The amplification was performed in separate tubes con-
taining a reaction mixture comprised of 2 μlD N A
(200 ng), 10 μl 5× Phusion HF buffer, 1 μl dNTPs (10 mM
each), 0.5 μl5 0m MM g C l 2 (final concentration 2 mM)
5 μl( 1 0μM) of each primer, 0.5 μl Phusion High Fidelity
Polymerase (2 U/μl, Finnzymes) and PCR-grade sterile
water to a final volume of 50 μl. Amplification of the tar-
gets was performed in a gradient Thermocycler (Biorad):
initial denaturation 98°C for 3 min, 30 cycles of 98°C for
10 s, annealing temperature (Tm + 3°C of the lower
primer) for 30 s and 72°C for 30 s and a final extension of
72°C for 3 min. The PCR products were purified using
QIAquick PCR Purification Kit (Qiagen) according to the
manufacturer’s instructions. The concentration and purity
of DNA were measured with the Nanodrop device and the
size of the amplicon determined by using an agarose gel
electrophoresis.
Agarose gel electrophoresis was carried out in a Per-
f e c t B l u eG e l s y s t e mM i n i( P e q l a b )f o r9 0m i na t8 0V .
T h eD N Aw a sv i s u a l i z e db ye t h i d i u mb r o m i d es t a i n i n g
and detected on a transilluminator. Hyper Ladder I (Bio-
line) served as a size reference.
Ligation and cloning
After the correct size was determined the purified PCR
product was used in restriction digest according to the
Flexi Vector System (Promega). Briefly, the DNA and the
acceptor vector, Flexi pFN18A (Promega) were cut by
SgfIa n dPmeI. For the reactions 500 ng of DNA were
mixed with 4 μl 5× Flexi Digest buffer, 4 μlo fF l e x i
Enzyme Blend (SgfIa n dPmeI) and the total volume
adjusted to 20 μl using nuclease-free water. Respectively,
200 ng of acceptor vector were cut after combining it
with 4 μl of 5× Flexi Digest buffer, 2 μl of Flexi Enzyme
Blend (SgfIa n dPmeI) and 12 μl of nuclease-free water.
The reactions were incubated for 30 min at 37°C. After-
wards, the reactions containing the different amplified
g e n e sw e r ep u r i f i e db yQ I A q u i c kP C RP u r i f i c a t i o nK i t
(Qiagen), whereas the digest of vector was heated for
20 min to 65°C to inactivate both enzymes. Directly after
purification and inactivation 4 μl of restricted DNA was
added to 10 μl2 ×l i g a s eb u f f e r ,5μl of digested acceptor
vector and 1 μlT 4D N AL i g a s e( H C ,2 0U / μl). The liga-
tion reaction proceeded for one hour at room
temperature.
The ligated constructs of vector and gene of interest
were cloned into KRX Single-Step Competent Cells
(Promega) by following the manufacturer’s instructions.
200 μl of each transformation reaction were spread on
LB Agar plates containing ampicillin (100 μg/ml). The
plates were incubated overnight at 37°C in an incubator.
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From each plate seven clones were selected and used as
templates in colony PCR. The reaction mixture contained
11.2 μl nuclease-free water, 4 μl 5× Phusion HF buffer,
0.4 μld N T P s( 1 0m Me a c h ) ,0 . 2μl5 0m MM g C l 2 (final
concentration 2 mM), 2 μl of each Primer (10 μM) and
0.2 μl of Phusion High Fidelity Polymerase. The colony
PCR and gel electrophoresis conditions were identical to
the ones described above.
Positive clones were used to inoculate 5 ml of lysogeny
broth containing ampicillin (LB-amp) and cultivated
under shaking conditions (270 rpm) at 37°C, until an opti-
cal density of OD600 = 0.6 was reached. The cell suspen-
sion was centrifuged (1000 g, 5 min). The supernatant was
discarded and the pellet resuspended in 0.9 ml of fresh
LB-amp. Subsequently 100 μl sterile DMSO (Roth) was
added. Clones were stored in cryo tubes at -80°C.
Protein expression, lysis and spotting of lysates to
HaloLink™ Slides
For protein expression, clones from cryo stocks were
used to inoculate 5 ml of LB-Amp and incubated for
8 h at 37°C in an incubation shaker. The temperature
and shaking were decreased to 18°C respectively 180 rpm.
Protein expression was induced by addition of 25 μlo f
20% sterile-filtrated L-Rhamnose (Promega). The incuba-
tion continued overnight. Lysis of cells was achieved using
EasyLyse Bacterial Protein Extraction Kit (Epicentre)
according to manufacterer’s instructions. Afterwards
lysates were spotted to HaloLink™ Slides (Promega) using
the QArray2 microarray spotter (Molecular Devices).
Humidity was set to 70% during spotting and the slides
were left in the humidity chamber for 1 h after spotting
was completed.
Immunoscreening on HaloLink™ Slides
The slides were washed after spotting with PBSI (1× PBS,
0.05% IGEPAL
® CA-630) and a 3 Well ProPlate™ mod-
ule (Grace Biolabs) was attached to each slide. Each
chamber was filled differently, as follows: Top chamber
with rabbit-polyclonal antibody to Campylobacter jejuni
(Acris, 5 μg/ml), middle chamber with rabbit-polyclonal
to HaloTag
® (Promega, 5 μg/ml) and bottom chamber
with PBS only. Incubation was performed for one hour at
Table 2 Overview of genes investigated.
Gene Primer Sequence (5’-3’)T m [°C] Length [bp] immunogenic
cjaA [EMBL: CAL35100] cjaA for TAAAGCGATCGCCATGAAAAAAATACTTCTAAGTGT 53 840 +
cjaA rev ATTAGTTTAAACAATTTTTCCACCTTCAATCA 59
hisJ [EMBL: CAL34871] hisJ for GGCTGCGATCGCCATGAAAAAAATATTAAGCATTGCTC 61 756 +
hisJ rev CAAAGTTTAAACTTCTAATTCATATTTTTTAATTAAAGTA 55
pal [EMBL: CAL34284] pal for ATATGCGATCGCCATGAAAAAAATTCTTTTTACTTC 55 498 +
pal rev GCACGTTTAAACTCTTGATAATTTAAATTCAGC 54
cfrA [EMBL: CAL34884] cfrA for TCAGGCGATCGCCATGAAAAAAATATGTCTATCAG 52 2091 +
cfrA rev GATGGTTTAAACAAAGTTACCATTGATAGAAATA 52
flaC [EMBL: CAL34857] flaC for TGTCGCGATCGCCATGATGATCTCTGATGCAACT 59 750 +
flaC rev GGGGGTTTAAACTTGTAATAAATTAGCAATTTTGCTT 59
flaA [EMBL: CAL35451] flaA for AACTGCGATCGCCATGGGATTTCGTATTAACACC 60 1719 +
flaA rev CCGTGTTTAAACCTGTAGTAATCTTAAAACATTTTG 54
peb1a [EMBL: CAL35041] peb1 for TAAAGCGATCGCCATGGTTTTTAGAAAATCTTTGT 56 780 +
peb1 rev AGGGGTTTAAACTAAACCCCATTTTTTCGCTA 61
cadF [EMBL: CAL35585] cadF for TAAAGCGATCGCCATGAAAAAAATATTCTTATGT 50 960 +
cadF rev TGTCGTTTAAACTCTTAAAATAAATTTAGCAT 49
pyrC [EMBL: CAL34413] pyrC for GCAGGCGATCGCCATGAAACTTAAAAATCCTTTAG 53 1008 -
pyrC rev ACGTGTTTAAACATGTTTTAATTGAAATTTCAAA 55
pseB [EMBL: CAL35407] pseB for GACCGCGATCGCCATGTTTAACAAAAAAAATATCT 52 1005 -
pseB rev TTCTGTTTAAACAAAACCTTCAGTATGATTGAT 55
gapA [EMBL: CAL35512] gapA for AACAGCGATCGCCATGGCTGTAAAAGTTGCTATAAATGGT 65 999 -
gapA rev CACAGTTTAAACAGCCTTATTTGCAATATATACTGCCA 65
argC [EMBL: CAL34379] argC for GTTCGCGATCGCCATGAAAATAAAAGTTGGGATTTTAG 60 1028 -
argC rev CTTGGTTTAAACCAAATTTGCAAAGAATTTAAGTC 59
The gene name, accession from EMBL, primer names and sequences, their melting points, length of gene and immunogenic characteristics of the encoded
protein are given
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washed with PBSI. Secondary antibody (goat polyclonal
to rabbit IgG conjugated with Chromeo™-547, Abcam,
10 μg/ml) was applied to each chamber. The slides were
incubated under gentle rocking for one hour at room
temperature in the dark. Finally, slides were washed with
PBSI, the ProPlate™ module was removed and the slides
were dried by a nitrogen stream. The scanning of each
slide was performed on an Axon Genepix 4200A laser
scanner (Molecular Devices) with the following settings:
532 nm laser, PMT 400, 40% power, lines to average 1,
10 μm resolution, standard green emission filter 575 nm.
Microarray analysis
The raw data of the microarray experiment [GEO:
GSE33295] was analyzed using OriginPro 8 G (Origi-
nLab). The local background of each spot was sub-
tracted from each spot’s intensity to gain relative
fluorescence intensities (RFI). The signals from chamber
one were corrected through substraction of RFIs of
chamber three to account for unspecific signals by sec-
ondary antibody immobilization alone. From the KRX
extract samples without HaloTag
® protein the median
and the standard deviation (SD) of the background are
calculated. For each sample the contrast is computed by:
c =

RFIs − median(b)


RFIs + median(b)

with RFIS the relative fluorescence intensity of each
spot and the median of the background median(b). As
samples were spotted in multiple replicates, mean con-
trast values and their respective standard deviations
were calculated. The cutoff was calculated using the
median and SD of the background:
cutoff =

(median(b) +5× SD(b) − median(b))


(median(b) +5× SD(b) + median(b))

Sequencing
Plasmids were isolated from 1 ml aliquots of uninduced
cells by QIAprep Spin Miniprep Kit (Qiagen) according
to the manufacturer’s instructions. The purified plasmid
DNA was eluted in 50 μl Tris-HCl (pH 8.5). Concentra-
tion and purity were determined by Nanodrop measure-
ments. Each plasmid was sent to Sequence Laboratories
Göttingen GmbH for sequencing using two different
sequencing primers HT7 F (5’ acatcggcccgggtctgaatc 3’)
and FLX R (5’ cttcctttcgggctttgttag 3’). The generated
sequences were aligned with the corresponding gene
sequences by global alignment with free-end gaps (mod-
ified Needleman-Wunsch) using Geneious Pro™ 5.4.4
(Biomatters).
SDS-PAGE
The expression of the desired HaloTag
® fusion proteins
was checked by SDS-PAGE. After lysis of cells, 2 μlo f
each protein extract was mixed with 1 μlo f1 0μMH a l o -
Tag
® Alexa 488 ligand. After addition of 7 μL1 ×T B S
(100 mM Tris, 150 mM NaCl, pH 7.6) the reaction was
incubated at room temperature for 30 minutes. 2 μlo f
each reaction were removed, mixed with 8 μlo f5 ×l o a d -
ing buffer (Fermentas) and 1 μl DTT and heated for
5 min at 70°C. The separation was performed on a Mini-
Protean TGX Gel (Biorad, any kD, 15 wells) in a Protean
II xi Cell chamber (Biorad) for 30 min at 200 V. As a size
reference PageRuler Plus prestained protein ladder
(Fermentas) was used in combination with HaloTag
®
standard protein (Promega). Fluorescence was measured
in a FLA-5100 (Fujifilm) with excitation at 473 nm.
Western Blot Analysis
For western blot analysis the samples were run on an
SDS-PAGE, the Gel blotted to a PVDF membrane using
the iBlot
® Western Blotting System (Life Technologies).
The blotting time was set to 7 minutes. After blotting,
membranes were rinsed with water and blocked for 1 h
in 5% fat-free milk powder in PBS with gentle rocking.
The membranes were then washed with PBS-Tween
(0.05%) twice for five minutes each. The primary anti-
body (4 μg/ml) was added in 1% fat-free milk powder in
PBS and incubation was performed for 1.5 h under gentle
rocking. Afterwards, membranes were washed twice with
PBS-Tween (0.05%). The AP-conjugated secondary anti-
bodies (4 μg/ml) were added in 1% fat-free milk powder
in PBS and incubation proceeded for 1 h under gentle
rocking. Finally, membranes were washed twice with
PBS-Tween and Western Blue
® stabilized substrate for
Alkaline Phosphatase (Promega) was added. After 5 min
the membrane was taken out, rinsed with water and
dried. A picture of the membrane was taken using Bio-
DocAnalyze digital and its software (Biometra).
Dot Blot
For dot blot analysis, 2 μl of the purified protein solution
were added as small droplets to a nitrocellulose membrane.
After drying, the membrane was blocked using 5% fat-free
milk powder in PBS for 1 h. The membrane was washed
twice with PBS-Tween (0.05%) and primary antibody (4 μg/
ml) was added in 1% fat-free milk powder in PBS. Incuba-
tion prolonged for 30 min with gentle rocking, afterwards
the membrane was washed twice as above and AP-conju-
gated secondary antibody (4 μg/ml) was added and incuba-
tion proceeded for additional 30 min. After a final two
washes, the Western Blue
® stabilized substrate for Alkaline
Phosphatase (Promega) was added and after 5 min the
membrane was rinsed with water. The visualization was
performed with the BioDocAnalyze digital software.
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The recombinantly expressed target-proteins were puri-
fied from whole lysates by using HaloLink™ magnetic
beads (Promega) according to the manufacturer’s
instructions. Subsequently, target protein was cleaved
off using ProTEV Plus Protease and the supernatant
used for SDS-PAGE.
Additional material
Additional file 1: Excel sheet comparing the codon usage of
Campylobacter jejuni NCTC 11168 and Escherichia coli strain K12.
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